Excited to announce that we are looking to grow our HF family by adding a full-time HF/HTx/MCS cardiologist here at USC! It will involve a leadership role in growing HF care at our partner hospitals as well as contributing to our AHF/MCS/transplant services. DM me if interested!
Dr. Nattiv presents novel surgical techniques for tMCs cannulation and explant. Including double transaxial pumps at time of exchange from Impella CP to 5.5 snd novel “K-VAD” ecmo configuration w direct LV unloading. #ISHLT2024@ISHLT
Excited to share my article from @FrontCVMedicine exploring advanced hemodynamics and cardiac energetics in the pursuit of the patient-specific tipping point in advanced heart failure and cardiogenic shock. @RyanTedfordMD@preventfailure@FudimMarat
https://t.co/SwGxSQ3QeG
Our new case report in @asaiojournal of a young woman with prior NICM and durable LVAD, with subsequent recovery and LVAD explantation, who had a successful pregnancy. @wolfsonaaron
Excited to see our recommendations for best statistical practice for analyzing waitlist urgency in @TheJHLT - a key question when evaluating organ transplantation policies
Great to work with
@gracelyden@danielyjohnson@JRGolbus@EpiSnyder
https://t.co/QIgsp2fTNH
Following the 2018 UNOS policy change, the rates of #HTx for higher acuity patients increased while the risk of rejection and treated rejection decreased over time without impacting the risk of hospitalization for rejection and infection. @ajay_vaidya
🔗: https://t.co/RxJq6AFg59
I’m delighted to join as faculty for this outstanding fellowship program
PITCH has great structured mentorship + formal training in @UChicagoPHS- get the necessary empirical skills to take on hard, important questions
@ABIMFoundation please reply here so we all understand what these MOC fees get us. Paying the >$3,000 to pass the general and interventional cardiology recert exams isn’t enough for you. Please explain why. No answer assumes greed. We will all wait…
#HFinductiontherapy is as important as cancer induction chemotherapy-
HF is as deadly as cancer is and HF GDMT improve outcomes. Initiate quadruple HF therapies as induction therapy and then consider add-on therapies as consolidation therapy in HFrEF. https://t.co/k3w94cnxmB
Smoking kills- through heart attacks, strokes, emphysema, and cancer. So we encourage patients to quit cigarettes.
Handgun ownership dramatically increases the risk of dying by suicide. So why don’t we encourage patients to quit handguns?
Congratulations to the Dr. Jon Kobashigawa, director of Advanced Heart Disease and the Heart Transplant Program in the Smidt Heart Institute at Cedars-Sinai, on being selected to receive the 2023 Lifetime Achievement Award from the @ISHLT at #ISHLT2023! 🎉 https://t.co/QF1DhURgaR